The Market

SWOT Analysis

Strengths

Proven Experience : 

  • Commercial launch 400 Hospitals and 400 Communities in China
  • 7x Patents and 11x Patents Application in Process with 34 awards in Hong Kong and China
  • Governments supporting in Beijing, Shenzhen, Jiangmen, Zhongshan and Hong Kong. 
  • Nearly US$600K+ funding in China and Hong Kong

Uniqueness : 

  • Improve Pharmacy Operation Efficiency by our 1st 3-in-1 RDDE of Refilling (Intelligence Verification), Extracting (Precise Robotic Clip and Arm) and Automatic Dispensing based on AI technology
  • 7×24 for Handling Prescription and non-Prescription Services

Weaknesses

Lack of Resources Allocation : 

  • Recruitment of new Team members / Advisory Board for enhance Healthcare operation knowhow
  • International Patent Application 
  • Funding for Global Expansion in Asian, EMEA and European Countries
  • Lack of Business Case outside Hong Kong and China

Opportunities

  • Pharmacy Automation for Healthcare Services Providers on              Prescription and Non-Prescription Services
  • AI Powered Customer Analytics for Government, Pharmaceutical and Insurance
  • Standardize Blister Pack and Avoid 2nd line Therapeutic Drugs
  • Integrate Mobile App with Telemedicine  / Online Ordering of Drugs 
  • Cater for the future development on Chinese Medicine

Threats

  • Decision making may be delayed by Government and Pharmaceutical  
  • Longer adaptation period will be expected for create new business strategies and project implementation
  • Longer revamping for system architecture design and migration processes due to existing system built by mix of multi-vendor and in-house development

Market Viability